Insights
Enterprise

How to gain exposure to Israel's economic growth

How to gain exposure to Israel's economic growth
Contents

U.S. and global investors continuously seek targeted allocation opportunities born out of geopolitical shifts and structural market mispricings. Over the past three years, Middle Eastern nations have navigated a complex geopolitical landscape; yet, one of the most compelling investment cases to emerge from this environment is the Israeli economy.

The current "Israeli Paradox" creates what we term "The Resilience Alpha": a stark disconnect between news sentiment and economic fundamentals. While headline noise has priced in a substantial risk discount on local assets, the underlying fundamentals of Israel's real economy continue to outpace broader OECD benchmarks, offering an attractive asymmetric risk/reward profile.

Beyond global recognition of the capabilities displayed by the Israeli defense industry, the resilience of the domestic economy is equally remarkable. Despite the headwinds of prolonged military engagement and elevated defense outlays, the macro picture remains robust.

Unemployment remains at historic lows, while the Bank of Israel projects 2026 GDP growth at 4.0%. Inflation has remained tightly contained: the CPI recorded a modest 1.5% year-over-year increase (as of July 2026), sitting comfortably within the central bank's target stability band. This low-inflation environment enabled the Bank of Israel to initiate monetary easing, lowering its interest rate to 3.50% (following a 25 bps cut in July 2026). This aligns the domestic policy interest rate closely with the Fed’s target range (3.50%–3.75%), maintaining a prudent framework that fosters favorable local growth conditions. Concurrently, the Israeli currency, the Shekel (ILS), has demonstrated exceptional strength, appreciating 12% vs the USD over the past year and 20% over the last 3 years, ranking among the world's top-performing currencies.

Beyond headline figures, Israel’s economic model rests on three core structural pillars:

  • R&D dominance: Israel is not merely a regional tech hub; it functions as the central innovation engine for global multinationals. As of 2024, Israel leads the OECD in R&D intensity, allocating 6.8% of GDP (compared to the OECD average of 2.7%). Hundreds of multinational R&D centers operate locally to capitalize on this unique ecosystem.
  • Monetary balance & FX reserves: The economy maintains substantial liquidity cushions to absorb external shocks. Foreign exchange reserves stand at $228–$232 billion (as of early 2026), representing roughly 37%–41% of GDP. Furthermore, energy independence achieved through natural gas exports provides domestic power price stability and a persistent USD revenue stream.
  • Demographic tailwinds: Israel maintains a unique demographic profile among developed markets, with a fertility rate of 2.9 births per woman (versus the OECD average of 1.5). This provides a sustained internal growth engine, shielding the market from the aging population crises affecting Western economies.

Israel vs. the OECD

(Data updated as of mid-2026 based on official forecasts and reports)

 
Economic / demographic Indicator Israel (Current) OECD average
Central Bank Interest Rate 3.50% (25 bps cut, July 2026) 2.15%–3.75%*
Inflation Rate (Annualized) 1.50% 4.20%
2026 GDP Growth Forecast 4.00% 0.90%
Gross Public Debt (% of GDP) 68% 108%–112%
R&D Investment (% of GDP) 6.80% 2.70%
High-Tech Share of Exports 56%–57% 15%–20%
Foreign Exchange Reserves (% of GDP) 37%–41% 10%–15%
Fertility Rate (Births per woman) 2.9 1.5
Annual Population Growth Rate 1.2%–1.5% 0.5%–0.65%


*OECD interest rates vary across member states. Figure represents the range across major member central banks (including the U.S., Eurozone, U.K., Canada, Australia, Japan, and Switzerland) as of mid-2026.

Why legacy Israel ETFs miss the domestic economy

When U.S. investors seek exposure to Israel’s macro story and "The Bounce-Back Phenomenon" —  the sharp economic recovery that has historically followed domestic security crises —  they often encounter a structural disconnect between their macro thesis and available ETFs. Most legacy U.S.-listed Israel ETFs are heavily weighted toward global technology or pharmaceutical companies. These products consist primarily of U.S.-listed ADRs whose core operations, revenues, and customer bases are located outside of Israel, offering less exposure to the Shekel or local economy.

For a U.S. investor already heavily allocated to global technology and the U.S. dollar, these legacy ETFs offer little meaningful diversification. Concentrating on multinational tech companies does not provide true exposure to the breadth of Israel’s economy or its unique domestic growth drivers. Pure-play exposure requires direct allocation to entities operating within the local market, currency exposure to the Shekel, broad sector diversification, and reduced correlation to U.S. big-tech indices.

Additionally, institutional market dynamics warrant attention: local pension funds and institutional managers control hundreds of billions of dollars in long-term domestic savings. These continuous structural inflows create constant demand for local equities and support asset price recoveries, a structural tailwind accessible primarily through direct domestic index exposure.

Israel 120 Index: 120 stocks, 100% Israel

The Israel 120 Index tracks the 120 largest market-cap companies listed on the Tel Aviv Stock Exchange. The index methodology strictly mandates that 100% of constituent companies trade locally on the Israeli exchange in Shekels (ILS). To mitigate concentration risk and ensure broad cross-sector representation, individual stock weights are hard-capped at 4%.

The index also incorporates a quantitative quality overlay: constituents reporting net operational losses in two or more of the preceding 5 years are subject to a weight penalty of up to 50%. This structure tilts index weighting toward balance-sheet stability and sustained profitability.

Methodological comparison vs. legacy ETFs 

To illustrate how the Israel 120 Index differs structurally from legacy U.S.-listed benchmarks:

 
Index name Number of holdings  Single-stock weight cap Rebalance frequency Asset listing venue Constituent trading currency
Israel 120 Index 120 4.00% Semi-Annual 100% Israel (TASE) 100% Shekel (ILS)
MSCI Israel Capped Investable Market Index 122 25.00% Quarterly Mixed (Israel, U.S. ADRs, Europe) Mixed (ILS, USD, GBP)
BlueStar Israel Global Index (BIGI) 80 10.00% Semi-Annual Mixed (Israel, U.S., International) Mixed (ILS, USD)
BlueStar Israel Global Tech Index 58 7.50% Semi-Annual Mixed (Israel, U.S. Tech) Mixed (ILS, USD)


While legacy Israeli ETFs expose investors to U.S. exchanges and USD revenues, the Israel 120 Index provides pure-play exposure to the Israeli Stock market and local currency performance.

Historical performance (in USD)

Data benchmarked against the S&P 500 demonstrates the portfolio diversification characteristics for U.S.-based investors:

 
Index name / (Ticker) Trailing 12-month return 3-Year cumulative return 5-Year cumulative return
Israel 120 Index (USD) 44.80% 168.56% 153.82%
MSCI Israel Capped Investable Market Index (EIS) 29.27% 134.72% 87.11%
BlueStar Israel Global Index (ISRA) 26.96% 92.74% 46.92%
S&P 500 Index (^GSPC) 20.86% 68.31% 73.60%
BlueStar Israel Global Tech (ITEQ) 18.41% 44.89% -3.44%

Data Source: Yahoo Finance & Guideline, as of June 30, 2026.

Conclusion

For global investors seeking to capture Middle Eastern market dynamics and Israeli macro expansion, the Israel 120 Index provides an institutional-grade gateway. Unlike legacy ETFs that hold U.S.-listed tech exposure denominated in USD, the Israel 120 Index methodology targets Israel's real domestic economy and local currency. By employing strict single-stock risk caps (4%), the index offers a structured way to reflect the underlying fundamentals of the domestic market.

Disclaimer: This content is for informational purposes only and does not constitute investment advice, a recommendation, solicitation, or endorsement. VettaFi utilizes research tools and artificial intelligence processing. The company does not guarantee the accuracy or completeness of the information, and its use is at the sole risk of the user. This information should not be viewed as a substitute for official company filings or documents. The information above does not constitute an offer to purchase shares or units in mutual funds; any such purchase must be made solely based on a valid prospectus and current immediate reports. The provision of this information does not substitute for personalized investment advisory services tailored to an individual’s financial profile or needs.

 

RELATED TOPICS

Related products

No items found.

Related products

No items found.

Related insights